Pharma

Pharmaceutical Cleaning Validation Market to Reach $28.40B by 2030
Manufacturing Pharmaceutical Cleaning Validation Market to Reach $28.40B by 2030

The global Pharmaceutical Cleaning Validation market is experiencing significant growth, projected to reach an impressive USD 28.40 billion by 2030. With a compound annual growth rate (CAGR) of 6.7% from 2024 to 2030, this market expansion underscores the critical importance of ensuring drug safety

Transformative Trends in Pharma Packaging: Safety and Patient Focus
Manufacturing Transformative Trends in Pharma Packaging: Safety and Patient Focus

The pharmaceutical packaging industry is on the cusp of significant changes as we move into 2024 and beyond, driven by innovations designed to enhance patient experience, ensure safety, and comply with evolving regulatory requirements. Dexter Tjoa, the CEO of Tjoapack, sheds light on the major

Theratechnologies Faces Supply Challenges Affecting HIV Drug Egrifta SV
Manufacturing Theratechnologies Faces Supply Challenges Affecting HIV Drug Egrifta SV

Theratechnologies, a Montreal-based pharmaceutical company, is grappling with an unexpected supply disruption of its HIV medication Egrifta SV. This drug, which serves to reduce excess abdominal fat in HIV patients with lipodystrophy, has encountered a significant hurdle stemming from the

Asamedic and Bormioli Partner to Launch Coxor for Heart Attack Emergencies
Manufacturing Asamedic and Bormioli Partner to Launch Coxor for Heart Attack Emergencies

In an unprecedented move set to revolutionize emergency cardiac care, Asamedic and Bormioli Pharma have formed a groundbreaking partnership to commercialize Coxor, a 300mg Acetylsalicylic acid medication designed for the urgent treatment of suspected acute myocardial infarction. Unlike traditional

Can ReciPredict Transform Drug Development and Manufacturing Processes?
Manufacturing Can ReciPredict Transform Drug Development and Manufacturing Processes?

Recipharm's latest innovation in the pharmaceutical industry, ReciPredict, is poised to revolutionize the drug development landscape. This cutting-edge platform is designed with Quality by Design (QbD) principles at its core, aiming to streamline tech transfers and manufacturing processes. By

GSK to Close Ulverston Antibiotics Plant, Shifting Focus to Innovation
Manufacturing GSK to Close Ulverston Antibiotics Plant, Shifting Focus to Innovation

In a significant strategic decision reflective of shifting priorities within the pharmaceutical industry, GSK has announced that it will close its 75-year-old antibiotics manufacturing facility in Ulverston, UK, by 2024. This move comes in the wake of the expiration of the company’s contract to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later